Cambridge Investment Research Advisors’s Ameren AEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.61M Sell
49,608
-1,026
-2% -$113K 0.01% 979
2026
Q1
$5.57M Sell
50,634
-935
-2% -$100K 0.01% 904
2025
Q4
$5.15M Buy
51,569
+2,919
+6% +$299K 0.01% 918
2025
Q3
$5.08M Buy
48,650
+2,669
+6% +$266K 0.01% 905
2025
Q2
$4.42M Sell
45,981
-10,644
-19% -$1.03M 0.01% 923
2025
Q1
$5.68M Sell
56,625
-7,594
-12% -$731K 0.02% 739
2024
Q4
$5.72M Sell
64,219
-11,102
-15% -$994K 0.02% 727
2024
Q3
$6.59M Buy
75,321
+14,251
+23% +$1.14M 0.02% 667
2024
Q2
$4.34M Sell
61,070
-813
-1% -$59.1K 0.02% 831
2024
Q1
$4.58M Sell
61,883
-261
-0.4% -$18.6K 0.02% 798
2023
Q4
$4.5M Sell
62,144
-1,171
-2% -$89.1K 0.02% 756
2023
Q3
$4.74M Buy
63,315
+11,592
+22% +$945K 0.02% 678
2023
Q2
$4.22M Buy
51,723
+3,018
+6% +$258K 0.02% 745
2023
Q1
$4.21M Sell
48,705
-455
-0.9% -$38.9K 0.02% 727
2022
Q4
$4.37M Sell
49,160
-2,888
-6% -$243K 0.02% 662
2022
Q3
$4.19M Buy
52,048
+4,877
+10% +$445K 0.02% 644
2022
Q2
$4.26M Sell
47,171
-6,086
-11% -$563K 0.02% 659
2022
Q1
$4.99M Buy
53,257
+1,176
+2% +$103K 0.02% 634
2021
Q4
$4.64M Buy
52,081
+818
+2% +$69.5K 0.02% 675
2021
Q3
$4.15M Sell
51,263
-1,474
-3% -$126K 0.02% 690
2021
Q2
$4.22M Buy
52,737
+281
+0.5% +$23.5K 0.02% 707
2021
Q1
$4.27M Buy
52,456
+8,827
+20% +$661K 0.02% 627
2020
Q4
$3.41M Buy
43,629
+5,771
+15% +$462K 0.02% 663
2020
Q3
$2.99M Buy
37,858
+3,986
+12% +$313K 0.02% 619
2020
Q2
$2.38M Buy
33,872
+370
+1% +$26.8K 0.02% 698
2020
Q1
$2.44M Buy
33,502
+1,188
+4% +$94.2K 0.02% 591
2019
Q4
$2.48M Buy
32,314
+4,054
+14% +$308K 0.02% 702
2019
Q3
$2.26M Buy
28,260
+1,732
+7% +$133K 0.02% 698
2019
Q2
$1.99M Buy
26,528
+1,476
+6% +$109K 0.02% 711
2019
Q1
$1.84M Buy
25,052
+821
+3% +$57.2K 0.02% 751
2018
Q4
$1.58M Sell
24,231
-541
-2% -$36.1K 0.02% 719
2018
Q3
$1.57M Buy
24,772
+2,436
+11% +$153K 0.02% 785
2018
Q2
$1.36M Buy
22,336
+1,504
+7% +$86.4K 0.01% 814
2018
Q1
$1.18M Buy
20,832
+2,440
+13% +$135K 0.01% 858
2017
Q4
$1.08M Buy
18,392
+1,597
+10% +$98.1K 0.01% 859
2017
Q3
$971K Buy
16,795
+1,903
+13% +$110K 0.01% 858
2017
Q2
$814K Buy
+14,892
New +$827K 0.01% 911
2016
Q4
Sell
-16,368
Closed -$805K 1674
2016
Q3
$805K Buy
+16,368
New +$835K 0.01% 782
2016
Q2
Sell
-20,856
Closed -$1.04M 1566
2016
Q1
$1.04M Buy
20,856
+511
+3% +$23.6K 0.02% 555
2015
Q4
$880K Buy
+20,345
New +$882K 0.02% 599
2015
Q3
Sell
-20,591
Closed -$776K 1444
2015
Q2
$776K Sell
20,591
-2,195
-10% -$88.1K 0.02% 607
2015
Q1
$962K Sell
22,786
-5,358
-19% -$233K 0.03% 517
2014
Q4
$1.3M Buy
28,144
+162
+0.6% +$6.89K 0.04% 409
2014
Q3
$1.07M Sell
27,982
-1,675
-6% -$65.5K 0.03% 495
2014
Q2
$1.21M Buy
29,657
+3,547
+14% +$141K 0.04% 399
2014
Q1
$1.08M Buy
26,110
+340
+1% +$13.1K 0.04% 404
2013
Q4
$932K Buy
25,770
+468
+2% +$16.8K 0.04% 418
2013
Q3
$882K Sell
25,302
-8,609
-25% -$298K 0.04% 408
2013
Q2
$1.17M Buy
+33,911
New +$1.18M 0.06% 287

Other funds holding AEE

Cambridge Investment Research Advisors's AEE Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Ameren (AEE) stake by 2% in Q2 2026, selling an estimated $113K and leaving 49,608 shares worth $5.61M. The position accounts for 0.01% of the portfolio, ranked #979.

Cambridge Investment Research Advisors first reported a position in AEE in Q2 2013 and has held it in 49 quarters since. The position peaked at $6.59M in Q3 2024. 944 funds tracked by Wall St. Rank hold AEE as of Q2 2026.

  • Cambridge Investment Research Advisors held 49,608 shares of Ameren worth $5.61M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 1,026 Ameren shares in Q2 2026, an estimated $113K.
  • Ameren made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #979 holding.
  • Cambridge Investment Research Advisors first reported a position in Ameren in Q2 2013 and has held it in 49 quarters since.
  • Cambridge Investment Research Advisors's Ameren position peaked at $6.59M in Q3 2024.
  • 944 funds tracked by Wall St. Rank held Ameren as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.